Abstract:Fatty acid-binding proteins (FABPs) are small cytoplasmic proteins involved in intracellular lipid transport and bind free fatty acids, cholesterol, and retinoids. FABP3, the major neuronal FABP in the adult brain, is upregulated in the CSF of patients with Alzheimer's disease (AD). However, the precise role of neuronal FABPs in AD pathogenesis remains unclear. This study investigates the contribution of fabp, the Drosophila homolog of FABP3 and FABP7, to amyloid β (Aβ) pathology using a Drosophila model. Neuronal knockdown of fabp shortened the lifespan of flies and increased age-related protein aggregates in the brain. In an AD model, fabp knockdown in neurons increased Aβ accumulation and Aβ-induced neurodegeneration, whereas fabp overexpression ameliorated Aβ pathology. Notably, fabp overexpression stimulated autophagy, which was inhibited by the knockdown of Eip75B , the Drosophila homolog of the peroxisome proliferator-activated receptor (PPAR). The PPAR activator rosiglitazone restored autophagy impaired by fabp knockdown and reduced fabp knockdown-induced increased Aβ aggregation and cell death. Furthermore, knockdown of either fabp or Eip75B in the wing imaginal disc or adult fly brain reduced the expression of Atg6 and Atg8a . Additionally, treatment of the fabp knockdown AD model flies with polyunsaturated fatty acids, such as docosahexaenoic acid or linoleic acid, partially alleviated cell death in the developing eye, restored impaired autophagy flux, reduced Aβ aggregation, and attenuated Aβ-induced cell death. Our results suggest that Drosophila fabp plays an important role in maintaining protein homeostasis during aging and protects neurons from Aβ-induced cell death by enhancing autophagy through the PPAR pathway. These findings highlight the potential importance of neuronal FABP function in AD pathogenesis. Alzheimer's disease (AD) is a neurodegenerative disease characterized by a gradual progression to severe cognitive impairment and dementia. Despite its high heritability, only a limited number of genes associated with AD have been identified. Understanding the role of disease-associated genes is critical to unraveling the pathology of AD. Given the abnormal protein aggregation seen in AD, genes that affect the degradation of aggregated proteins are expected to be important players. In this study, we focused on FABP, a lipid transport protein that has been observed at elevated levels in the cerebrospinal fluid of patients with AD. The specific role of this protein in neurons affected by AD remained elusive. Using a Drosophila model of AD, we found that reduced expression of fabp in neurons increased accumulation of amyloid β (Aβ) and exacerbated Aβ-induced neurodegeneration. Conversely, overexpression of fabp attenuated these phenotypes. Our results confirm that the protective effect of fabp is mediated through autophagy. In particular, we identified the involvement of the nuclear receptor PPAR in this process. We also demonstrated that neuronal fabp plays a critical role in protein aggregation and lifespan during aging. In conclusion, our study highlights the critical role of neuronal FABP as a regulator in AD pathology and aging. These findings contribute to a better understanding of the molecular mechanisms underlying AD and open avenues for potential therapeutic interventions.

Cellular Localization of Epidermal‐type and Brain‐type Fatty Acid‐binding Proteins in Adult Hippocampus and Their Response to Cerebral Ischemia

Fatty Acid-Binding Proteins Aggravate Cerebral Ischemia-Reperfusion Injury in Mice.

Astrocyte fatty acid binding protein‐7 is a marker for neurogenic niches in the rat hippocampus

FABP7 Protects Astrocytes Against ROS Toxicity via Lipid Droplet Formation

Astrocyte-derived Fatty Acid-Binding Protein 7 Protects Blood-Brain Barrier Integrity Through a Caveolin-1/Mmp Signaling Pathway Following Traumatic Brain Injury

Impact of Brain Fatty Acid Signaling on Peripheral Insulin Action in Mice.

Fatty acid-binding protein 7 gene deletion promotes decreases in brain cannabinoid type 1 receptor binding

Blood–Brain Barrier Disruption Mediated by FFA1 Receptor—Evidence Using Miniscope

Discrete localization of various fatty-acid-binding proteins in various cell populations of mouse retina

The Expression and Its Significance of Brain-Derived Neurotrophic Factor in Different Hippocampal Subfields after Focal Cerebral Ischemia in Rats

Potential safety implications of fatty acid-binding protein inhibition

Glia-derived secretory fatty acid binding protein Obp44a regulates lipid storage and efflux in the developing brain

Protein Expression Profiling in the Hippocampus after Focal Cerebral Ischemia Injury in Rats

Changes of P-Creb and C-Fos Expression in the Hippocampus of Neonatal Rats after Hypoxic-Ischemic and Reperfusion Brain Damage

The neuroprotective effect of short-chain fatty acids against hypoxia-reperfusion injury

Histopathological Changes of the Hippocampus Neurons in Brain Injury.

Neuronal fatty acid-binding protein enhances autophagy and suppresses amyloid-β pathology in a Drosophila model of Alzheimer's disease

Enriched Endogenous Omega-3 Fatty Acids in Mice Protect Against Global Ischemia Injury

Fatty Acid-Binding Protein 3 Contributes to Ischemic Heart Injury by Regulating Cardiac Myocyte Apoptosis and MAPK Pathways.

Brain-specific fatty acid-binding protein is elevated in serum of patients with dementia-related diseases

FABP7 upregulation induces a neurotoxic phenotype in astrocytes